Probity Medical Research Inc. (PMR)’s Post

Watch #heartfailure expert Dr. James Udelson, Tufts Medical Center, and Prof. Ian T. Meredith continue their conversation on the evidence around #interatrialshunting for #hfpef. In this second installment of our miniseries, they go deeper into RELIEVE-HF and the role of exercise right heart catheterization, an important diagnostic tool being utilized in #heartfailure trials like #ALLAYHF for #hfpef patients. “We need to keep pursuing avenues that might benefit patients, and follow the science.” - Dr. James Udelson

By moving away from the one-size-fits-all model of treatment, this evolving field promises more accurate diagnoses, better-targeted therapies, and improved patient outcomes. #personalizedmedicine #woundcare #doctor

Ibrutinib-containing regimens may be the “preferred” first-line treatment for younger patients with #MCL, and most patients may be able to forgo ASCT, Dr Martin Dreyling of LMU Klinikum München said at #ASH24. https://bit.ly/4f4zEqc #lymsm

🌐#FYA2024 Symposium On-Demand Ep. 14 🔓Unlock key skills in arterial management 📽️Watch in full here👉 https://ow.ly/jyqe50RHWwn 🌟Dr Hany Zayed discusses the use of deep venous arterialisation in no-option patients, outlining patient selections and strategies, procedural steps and follow-up.

If you have been practicing #IntermittentFasting (IF), here's some good news: adding to the list of benefits, it seems that IF may be good for #vasculardementia and related vascular cognitive impairments (VCI) as well. First authored by Dr. Vismitha Rajeev and Nishat Tabassum, and led by Thiruma Arumugam, this paper provides a comprehensive overview of the available data supporting IF's potential in treating VCI by emphasizing the underlying mechanisms, and lends support for further evaluation of IF in clinical trials for both existing and at-risk VCI patients. Open-access full text below:

Are you a healthcare professional managing patients with #MultipleMyeloma? If yes, you are invited to join us for an interactive webinar focused on optimising the management of early RRMM. In this session, experts Assoc. Prof. Karthik Ramasamy, Prof. Aurore Perrot, Prof. Hermann Einsele, and Assoc. Prof. Joshua Richter will discuss the challenges of sequencing and combining treatment options to enhance outcomes for patients with #RRMM. ⏰To register: https://ow.ly/FiMi50RQvXT #mmsm #MedEd

Pathology is essential for identifying illness, expanding medical knowledge, promoting public health and making valuable contributions to society that enhance patient care. Our commitment is to assist you in meeting the increasing demand for testing by thoroughly examining every possible opportunity for improvement, ultimately enhancing your laboratory's efficiency and productivity. To ensure your lab performs at its best, it's crucial to understand what’s happening, how it’s happening and why. Access to accurate, relevant and timely information is critical for optimizing your day-to-day lab workflow. To learn more, visit https://lnkd.in/eFXavUQU #InternationalPathologyDay #PathLabs #Laboratory #Diagnostics #QuidelOrtho #QuidelOrthoANZ

Between 2013 and 2018, the number of #Medicare patients with non-traumatic #SCI increased by more than 22%, patient complexity increased, and median length-of-stay remained at 12 days year-to-year. Read more about the research led by #CROR scientist, Anne Deutsch, PhD, RN and Allison Kessler Vear of Shirley Ryan AbilityLab together with Jennifer Burns and John Potelle of RTI International  https://loom.ly/Wh1y8yU

Texas A&M Health Adopts Genomic Decision Support for Clinical Care https://lnkd.in/g-h-7ac4 Texas A&M Health is partnering with ActX, a leading genomic decision support vendor, to bring a precision medicine approach to routine patient care. SEATTLE, Jan. 8, 2025 /PRNewswire-PRWeb/ — Texas A&M Health is partnering with [...]

Day 2 at #TCT2024 is underway! Join Terumo Health Outcomes at Booth 1603 and discover how ePRISM can help clinical staff identify at-risk patients before procedures even begin, leading to better care and fewer complications. Precision medicine is here — let’s talk about how we can help! #TCT2024